Amgen has completed the acquisition of more than 99% of the shares of Mustafa Nevzat Pharmaceuticals (MN Pharmaceuticals), a privately held Turkish company.
The all-cash transaction is expected to expand Amgen's presence in Turkey and the surrounding region.
The acquisition was initially announced on 25 April 2012.
MN Pharmaceuticals, a manufacturer of injectable products, was established in 1923 in a district of Istanbul known as Uskudar, Ihsaniye under the name of Mustafa Nevzat Laboratory.
Amgen, a biotechnology company, discovers, develops, manufactures and delivers human therapeutics.
Source:
http://inwardinvestment.pharmaceutical-business-review.com/news/amgen-takes-over-more-than-99-of-mn-pharmaceuticals-shares-130612